z-logo
open-access-imgOpen Access
Molecular Imaging Reveals Rapid Reduction of Endothelial Activation in Early Atherosclerosis With Apocynin Independent of Antioxidative Properties
Author(s) -
Elham Khanicheh,
Yue Qi,
Aris Xie,
Martina Mitterhuber,
Lifen Xu,
Michika Mochizuki,
Youssef Daali,
Vincent Jaquet,
Karl-Heinz Krause,
Zaverio M. Ruggeri,
Gabriela M. Kuster,
Jonathan R. Lindner,
Beat A. Kaufmann
Publication year - 2013
Publication title -
arteriosclerosis thrombosis and vascular biology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.007
H-Index - 270
eISSN - 1524-4636
pISSN - 1079-5642
DOI - 10.1161/atvbaha.113.301710
Subject(s) - apocynin , nadph oxidase , reactive oxygen species , nicotinamide adenine dinucleotide phosphate , superoxide , chemistry , pharmacology , cell adhesion molecule , oxidative stress , western blot , biochemistry , medicine , oxidase test , immunology , enzyme , gene
Antioxidative drugs continue to be developed for the treatment of atherosclerosis. Apocynin is an nicotinamide adenine dinucleotide phosphate oxidase inhibitor with anti-inflammatory properties. We used contrast-enhanced ultrasound molecular imaging to assess whether short-term apocynin therapy in atherosclerosis reduces vascular oxidative stress and endothelial activation

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom